You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
The evaluation of pharmacoeconomics of thiazolidinedione class of antidiabetic agents-a retrospective study
- In: Hospital Pharmacy Section - Posters
- At: Beijing (China) (2007)
- Type: Poster
- Poster code: HPS-P-088
- By: HUANG, Chiu-Ku (Tainan Municipal Hospital, Tainan, China Taiwan)
- Co-author(s): Wang, Er-Ting (Tainan Municipal Hospital, Tainan, China Taiwan)
- Abstract:
Aim: The drugs to ameliorate insulin resistance are PPAR-g（peroxisome proliferator-activated receptor-g）, including rosiglitazone and pioglitazone in Taiwan. The class of hypoglycemic agents was approved to decrease HbA1C, elevate HDL and decrease glucose level in patients with type 2 DM in clinical trials, which following time are about half
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026